HRMY
Price
$33.55
Change
-$0.08 (-0.24%)
Updated
Dec 18, 04:18 PM (EDT)
63 days until earnings call
SNBIF
Price
$5.81
Change
+$1.96 (+50.91%)
Updated
Dec 11 closing price
Ad is loading...

HRMY vs SNBIF

Header iconHRMY vs SNBIF Comparison
Open Charts HRMY vs SNBIFBanner chart's image
Harmony Biosciences Holdings
Price$33.55
Change-$0.08 (-0.24%)
Volume$100
CapitalizationN/A
Sanbio
Price$5.81
Change+$1.96 (+50.91%)
Volume$2.93K
CapitalizationN/A
HRMY vs SNBIF Comparison Chart
Loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRMY vs. SNBIF commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMY is a Hold and SNBIF is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (HRMY: $33.63 vs. SNBIF: $5.81)
Brand notoriety: HRMY and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRMY: 59% vs. SNBIF: 242%
Market capitalization -- HRMY: $1.92B vs. SNBIF: $378.53M
HRMY [@Biotechnology] is valued at $1.92B. SNBIF’s [@Biotechnology] market capitalization is $378.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRMY’s FA Score shows that 0 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • HRMY’s FA Score: 0 green, 5 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than SNBIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRMY’s TA Score shows that 3 TA indicator(s) are bullish while SNBIF’s TA Score has 1 bullish TA indicator(s).

  • HRMY’s TA Score: 3 bullish, 5 bearish.
  • SNBIF’s TA Score: 1 bullish, 2 bearish.
According to our system of comparison, SNBIF is a better buy in the short-term than HRMY.

Price Growth

HRMY (@Biotechnology) experienced а +0.45% price change this week, while SNBIF (@Biotechnology) price change was +50.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

HRMY is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($1.92B) has a higher market cap than SNBIF($379M). SNBIF YTD gains are higher at: 47.089 vs. HRMY (4.118). HRMY has higher annual earnings (EBITDA): 218M vs. SNBIF (-1.57B). SNBIF has more cash in the bank: 3.96B vs. HRMY (410M). HRMY has less debt than SNBIF: HRMY (183M) vs SNBIF (598M). HRMY has higher revenues than SNBIF: HRMY (682M) vs SNBIF (0).
HRMYSNBIFHRMY / SNBIF
Capitalization1.92B379M506%
EBITDA218M-1.57B-14%
Gain YTD4.11847.0899%
P/E Ratio15.94N/A-
Revenue682M0-
Total Cash410M3.96B10%
Total Debt183M598M31%
FUNDAMENTALS RATINGS
SNBIF: Fundamental Ratings
SNBIF
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRMYSNBIF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
43%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
38%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
11%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
6%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Ad is loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPHR38.01-0.04
-0.11%
Sphere Entertainment Co
ONEW20.56-0.19
-0.92%
OneWater Marine
ELV366.30-7.00
-1.88%
Elevance Health
RLI166.88-3.39
-1.99%
RLI Corp
ENZ0.70-0.31
-30.69%
Enzo Biochem

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
+1.72%
SNBIF - HRMY
52%
Loosely correlated
N/A
SAGE - HRMY
39%
Loosely correlated
-1.40%
ANAB - HRMY
39%
Loosely correlated
-3.96%
RVNC - HRMY
39%
Loosely correlated
-0.65%
GYRE - HRMY
38%
Loosely correlated
+11.31%
More

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with BLPH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then BLPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
BLPH - SNBIF
61%
Loosely correlated
N/A
HRMY - SNBIF
52%
Loosely correlated
+1.72%
QRON - SNBIF
34%
Loosely correlated
+1.10%
CING - SNBIF
28%
Poorly correlated
+0.99%
WXXWY - SNBIF
28%
Poorly correlated
-0.99%
More